Cargando…

Four Faces of Cell-Surface HLA Class-I: Their Antigenic and Immunogenic Divergence Generating Novel Targets for Vaccines

Leukocyte cell-surface HLA-I molecules, involved in antigen presentation of peptides to CD8+ T-cells, consist of a heavy chain (HC) non-covalently linked to β2-microglobulin (β2m) (Face-1). The HC amino acid composition varies across all six isoforms of HLA-I, while that of β2m remains the same. Eac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ravindranath, Mepur H., Ravindranath, Narendranath M., Selvan, Senthamil R., Filippone, Edward J., Amato-Menker, Carly J., El Hilali, Fatiha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878457/ https://www.ncbi.nlm.nih.gov/pubmed/35214796 http://dx.doi.org/10.3390/vaccines10020339

Ejemplares similares

Cell Surface B2m-Free Human Leukocyte Antigen (HLA) Monomers and Dimers: Are They Neo-HLA Class and Proto-HLA?
por: Ravindranath, Mepur H., et al.
Publicado: (2023)

Antibodies for β2-Microglobulin and the Heavy Chains of HLA-E, HLA-F, and HLA-G Reflect the HLA-Variants on Activated Immune Cells and Phases of Disease Progression in Rheumatoid Arthritis Patients under Treatment
por: Ravindranath, Mepur H., et al.
Publicado: (2023)

Role of HLA-I Structural Variants and the Polyreactive Antibodies They Generate in Immune Homeostasis
por: Ravindranath, Mepur H., et al.
Publicado: (2022)

Ramifications of the HLA-I Allelic Reactivity of Anti-HLA-E*01:01 and Anti-HLA-E*01:03 Heavy Chain Monoclonal Antibodies in Comparison with Anti-HLA-I IgG Reactivity in Non-Alloimmunized Males, Melanoma-Vaccine Recipients, and End-Stage Renal Disease Patients
por: Ravindranath, Mepur H., et al.
Publicado: (2022)

Therapeutic Potential of HLA-I Polyreactive mAbs Mimicking the HLA-I Polyreactivity and Immunoregulatory Functions of IVIg
por: Ravindranath, Mepur H., et al.
Publicado: (2021)

The Impact of Inflammation on the Immune Responses to Transplantation: Tolerance or Rejection?
por: Ravindranath, Mepur H., et al.
Publicado: (2021)

HLA Class Ia and Ib Polyreactive Anti-HLA-E IgG2a Monoclonal Antibodies (TFL-006 and TFL-007) Suppress Anti-HLA IgG Production by CD19+ B Cells and Proliferation of CD4+ T Cells While Upregulating Tregs
por: Ravindranath, Mepur H.
Publicado: (2017)

Enhancing Natural Killer and CD8(+) T Cell-Mediated Anticancer Cytotoxicity and Proliferation of CD8(+) T Cells with HLA-E Monospecific Monoclonal Antibodies
por: Ravindranath, Mepur H., et al.
Publicado: (2019)

The Humoral Theory of Transplantation
por: Ravindranath, Mepur H., et al.
Publicado: (2017)

Significance of the intraindividual variability of HLA IgG antibodies in renal disease patients observed with different beadsets monitored with two different secondary antibodies on a Luminex platform
por: Ravindranath, Mepur H., et al.
Publicado: (2018)

Epicatechins Purified from Green Tea (Camellia sinensis) Differentially Suppress Growth of Gender-Dependent Human Cancer Cell Lines
por: Ravindranath, Mepur H., et al.
Publicado: (2006)

Melanoma and Human Leukocyte Antigen (HLA): Immunogenicity of 69 HLA Class I Alleles With 11 Antigens Expressed in Melanoma Tumors
por: Georgopoulos, Apostolos P, et al.
Publicado: (2023)

Differential Growth Suppression of Human Melanoma Cells by Tea (Camellia sinensis) Epicatechins (ECG, EGC and EGCG)
por: Ravindranath, Mepur H., et al.
Publicado: (2009)

Humoral Alloimmunity in Transplantation: Relevance of HLA Epitope Antigenicity and Immunogenicity
por: Duquesnoy, René J.
Publicado: (2011)

HLA antigens in colorectal tumours--low expression of HLA class I antigens in mucinous colorectal carcinomas.
por: van den Ingh, H. F., et al.
Publicado: (1987)

Human leukocyte antigen (HLA) class II peptide flanking residues tune the immunogenicity of a human tumor-derived epitope
por: MacLachlan, Bruce J., et al.
Publicado: (2019)

ROLE OF HLA CLASS-I ANTIGENS IN DELUSIONAL DISORDER
por: Debnath, Monojit, et al.
Publicado: (2000)

Differences in Immunogenicity of HLA Antigens and the Impact of Cross-Reactivity on the Humoral Response
por: Lucas, Donna P., et al.
Publicado: (2015)

Immunogenicity of HLA Class I and II Double Restricted Influenza A-Derived Peptides
por: Pedersen, Sara Ram, et al.
Publicado: (2016)

Identification of HLA class I-restricted immunogenic neoantigens in triple negative breast cancer
por: Aparicio, Belén, et al.
Publicado: (2022)

Quality Assurance and Average Glandular dose Measurement in Mammography Units
por: Selvan, C. Senthamil, et al.
Publicado: (2017)

Proteome Sampling by the HLA Class I Antigen Processing Pathway
por: Hoof, Ilka, et al.
Publicado: (2012)

The Association of HLA Class 1 and Class 2 Antigens with Multiple Myeloma in Iranian Patients
por: Sayad, Arezou, et al.
Publicado: (2014)

The association between chronic spontaneous urticaria and HLA class I and class II antigen
por: DOĞAN, Neslihan, et al.
Publicado: (2020)

The Immunogenicity of HLA Class II Mismatches: The Predicted Presentation of Nonself Allo-HLA-Derived Peptide by the HLA-DR Phenotype of the Recipient Is Associated with the Formation of DSA
por: Jucaud, Vadim
Publicado: (2017)

Combining deep mutational scanning to heatmap of HLA class II binding of immunogenic sequences to preserve functionality and mitigate predicted immunogenicity
por: Sivelle, Coline, et al.
Publicado: (2023)

Hapten-Induced Contact Hypersensitivity, Autoimmune Reactions, and Tumor Regression: Plausibility of Mediating Antitumor Immunity
por: Erkes, Dan A., et al.
Publicado: (2014)

“Adherent” versus Other Isolation Strategies for Expanding Purified, Potent, and Activated Human NK Cells for Cancer Immunotherapy
por: Selvan, Senthamil R., et al.
Publicado: (2015)

Use of HLA peptidomics and whole exome sequencing to identify human immunogenic neo-antigens
por: Kalaora, Shelly, et al.
Publicado: (2016)

Direct evidence for binding of CD8 to HLA class I antigens
Publicado: (1989)

HLA-DO and Its Role in MHC Class II Antigen Presentation
por: Poluektov, Yuri O., et al.
Publicado: (2013)

Human Leukocyte Antigen (HLA) class I and II datasets for sudanese
por: Dafalla, Ameer Mohamed, et al.
Publicado: (2019)

Expression of classical human leukocyte antigen class I antigens, HLA‐E and HLA‐G, is adversely prognostic in pancreatic cancer patients
por: Hiraoka, Nobuyoshi, et al.
Publicado: (2020)

HLA-A, B (Class I) and HLA-DR, DQ (Class II) Antigens in Turkish Patients with Recurrent Aphthous Ulceration and Behçet's Disease
por: Pekiner, Filiz Namdar, et al.
Publicado: (2013)

Influence of DM-sensitivity on immunogenicity of MHC class II restricted antigens
por: Bernhardt, Anna Luise, et al.
Publicado: (2021)

Evaluation of antiarthritic activity of Strychnos potatorum Linn seeds in Freund's adjuvant induced arthritic rat model
por: Ekambaram, Sanmugapriya, et al.
Publicado: (2010)

Autoimmunity in Reproductive Health and Pregnancy
por: Tabarkiewicz, Jacek, et al.
Publicado: (2018)

In vivo antiarthritic activity of the ethanol extracts of stem bark and seeds of Calophyllum inophyllum in Freund’s complete adjuvant induced arthritis
por: Perumal, Senthamil Selvan, et al.
Publicado: (2016)

Proteogenomic identification of an immunogenic HLA class I neoantigen in mismatch repair–deficient colorectal cancer tissue
por: Hirama, Tomomi, et al.
Publicado: (2021)

An Approach to Identify HLA Class II Immunogenic Epitopes in the Greek Population through Machine Learning Algorithms
por: Fylaktou, Asimina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r1c0scfmqqnmofljprmq61h4o2